ATE504301T1 - Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen - Google Patents

Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen

Info

Publication number
ATE504301T1
ATE504301T1 AT08700996T AT08700996T ATE504301T1 AT E504301 T1 ATE504301 T1 AT E504301T1 AT 08700996 T AT08700996 T AT 08700996T AT 08700996 T AT08700996 T AT 08700996T AT E504301 T1 ATE504301 T1 AT E504301T1
Authority
AT
Austria
Prior art keywords
lung disease
obstructive lung
early treatment
sodium
blockers
Prior art date
Application number
AT08700996T
Other languages
English (en)
Inventor
Marcus Mall
Original Assignee
Univ Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Heidelberg filed Critical Univ Heidelberg
Application granted granted Critical
Publication of ATE504301T1 publication Critical patent/ATE504301T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT08700996T 2007-01-08 2008-01-07 Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen ATE504301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07000267A EP1941883A1 (de) 2007-01-08 2007-01-08 Verwendung von Natriumblockern zur frühzeitigen Behandlung von obstruktiven Lungenerkrankungen
PCT/EP2008/000051 WO2008083942A1 (en) 2007-01-08 2008-01-07 Use of sodium blockers for an early therapy of obstructive lung diseases

Publications (1)

Publication Number Publication Date
ATE504301T1 true ATE504301T1 (de) 2011-04-15

Family

ID=38093414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08700996T ATE504301T1 (de) 2007-01-08 2008-01-07 Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen

Country Status (5)

Country Link
US (1) US20090312348A1 (de)
EP (2) EP1941883A1 (de)
AT (1) ATE504301T1 (de)
DE (1) DE602008006024D1 (de)
WO (1) WO2008083942A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201922239A (zh) * 2017-10-04 2019-06-16 英商尼姆生物技術有限公司 藥學組成物及其用途
WO2023275622A2 (en) * 2021-07-01 2023-01-05 Aquapass Ltd Methods and devices for modulating electrolyte excretion
CN116211863B (zh) * 2023-03-15 2025-07-18 山东大学 阿米洛利在制备防治感染性心内膜炎或抑制其病原菌药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501729A (en) * 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
KR930701992A (ko) * 1990-10-05 1993-09-08 웨인 알.조운즈 환자의 폐에 잔존하는 점액 분비물의 제거 방법
JP4633927B2 (ja) * 1998-05-22 2011-02-16 インスパイアー ファーマシューティカルズ,インコーポレイティド 治療用ジヌクレオチドおよび誘導体
CA2575670A1 (en) * 2004-08-18 2006-03-02 Michael R. Johnson Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers

Also Published As

Publication number Publication date
US20090312348A1 (en) 2009-12-17
EP2114407A1 (de) 2009-11-11
DE602008006024D1 (de) 2011-05-19
EP1941883A1 (de) 2008-07-09
EP2114407B1 (de) 2011-04-06
WO2008083942A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
EA201000105A1 (ru) Химические соединения
EA201100255A1 (ru) 5-алкинилпиримидины
EA201071144A1 (ru) Гетероциклические производные
CU20110119A7 (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematológicas
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA200802213A1 (ru) Способы лечения заболеваний крови
EA201100254A1 (ru) Новые соединения
EA200702387A1 (ru) Имидазохинолины в качестве ингибиторов липидкиназы
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
GT201200164A (es) "nuevos compuestos de espiropiperidina"
GB2496794A (en) Combination pharmaceutical composition and methods of treating and methods of treating functional diseases or conditions of gastrointestinal tract
EA201400521A1 (ru) Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения
MY153408A (en) Novel methods
MY137477A (en) Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
MX2009006913A (es) Uso de derivados de acido de piranona sustituidos para el tratamiento del sindrome metabolico.
WO2011113507A3 (en) Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
BR112014008783A2 (pt) compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório
EA201001427A1 (ru) Тиазолилдигидроиндазолы
ATE504301T1 (de) Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции
EA201101517A1 (ru) 5-алкинилпиридины
DOP2010000156A (es) Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
EA201390925A1 (ru) Производные санглиферина и способы их получения
MX2010000120A (es) Estereoisomeros de triciclodecan-9-il-xantogenato.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties